NCT02839382
- Conditions
- Cardiovascular Disease, Cardiovascular Diseases, Chemically-Induced Disorders, +13 more
- Locations
-
- GroupHealthCoop Seattle, Washington, United States
Clinical trial condition
Hyperlipidemia
Explore clinical trials studying Hyperlipidemia. Study availability and eligibility vary by location and protocol.
343 public trials
22 recruiting studies
Hyperlipidemia trial results
NCT02153073
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Osaka, Japan
- Tokyo, Japan
Completed
Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable Diseases
NCT02905448
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +22 more
- Locations
-
Not specified
NCT01763918
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site Cincinnati, Ohio, United States
- Research Site Camperdown, New South Wales, Australia
- Research Site Perth, Western Australia, Australia
NCT02512276
- Conditions
- Behavior, Cardiovascular Diseases, Diabetes, +16 more
- Locations
-
- Harvard Vanguard Medical Associates Newton, Massachusetts, United States
NCT02824432
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Yufu, Oita Prefecture, Japan
- Shinjuku, Tokyo, Japan
- Kagoshima, Japan
- Ōita, Japan
NCT02742545
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Cardiovascular Diseases, +10 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Completed
A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol
NCT01426412
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Glendale, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madison, Wisconsin, United States
NCT01607294
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +8 more
- Locations
-
- Miramar, Florida, United States
Completed
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
NCT02659397
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemia, +4 more
- Locations
-
- Anaheim, California, United States
- Los Angeles, California, United States
- Northridge, California, United States
- Clearwater, Florida, United States